CRTH2 expression on T cells in asthma
Open Access
- 20 May 2010
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 161 (1), 34-40
- https://doi.org/10.1111/j.1365-2249.2010.04161.x
Abstract
Mast cell-derived prostaglandin D2 (PGD2) is the major prostanoid found within the airway of asthmatics immediately following allergen challenge. PGD2 has been shown to have chemokinetic effects on eosinophils and T helper type 2 (Th2) cells in vitro. This occurs through the interaction of PGD2 with the G-protein-coupled chemokine receptor homologous molecule expressed on Th2 lymphocytes (CRTH2). The expression of CRTH2 has been shown to be highly selective for Th2 cells. Using flow cytometry we have studied the expression of CRTH2 on T cells in blood and bronchoalveolar lavage fluid in asthmatics and normal subjects. CRTH2 expression was confined to a small percentage of blood T cells in asthmatics (1·8% ± 0·2) and normal (1·6% ± 0·2) subjects. CRTH2 was enriched significantly on interleukin (IL)-4+/IL-13+ T cells compared to interferon (IFN)-γ+ T cells (P < 0·001). There was a small population of CRTH2+ T cells in the bronchoalveolar lavage (BAL) of asthmatics (2·3% ± 0·6) and normal subjects (0·3% ± 0·1), and there was a significant difference between the two groups (P < 0·05). There were similar amounts of PGD2 in the BAL of asthma and normal subjects. Within paired blood–BAL samples from the same subject there was no increase in CRTH2+ T cells in the BAL compared to blood in asthmatics. Enrichment of CRTH2 on IL-4+ and IL-13+ T cells compared to IFN-γ+ T cells was also seen in BAL from asthmatics (P < 0·001). CRTH2 is expressed preferentially by IL-4+/IL-13+ T cells compared to IFN-γ+ T cells. However, given their small numbers they are unlikely to have a significant involvement in the pathogenesis of asthma. CRTH2 antagonism may not diminish T cell accumulation in the asthmatic lung.Keywords
This publication has 21 references indexed in Scilit:
- The roles of the prostaglandin D2 receptors DP1 and CRTH2 in promoting allergic responsesBritish Journal of Pharmacology, 2008
- Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseasesNature Reviews Drug Discovery, 2007
- A dominant role for chemoattractant receptor‐homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatantsImmunology, 2006
- IL-4–expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR3 and CCR4Journal of Allergy and Clinical Immunology, 2005
- Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell responseEuropean Journal of Immunology, 2005
- Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 ReceptorJournal of Pharmacology and Experimental Therapeutics, 2004
- Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stabilityHuman Molecular Genetics, 2004
- An Orally Bioavailable Small Molecule Antagonist of CRTH2, Ramatroban (BAY u3405), Inhibits Prostaglandin D2-Induced Eosinophil Migration in VitroJournal of Pharmacology and Experimental Therapeutics, 2003
- Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DPJournal of Allergy and Clinical Immunology, 2001
- BAY u3405, a Thromboxane A2 Antagonist, Reduces Bronchial Hyperresponsiveness in AsthmaticsChest, 1996